Changes in antiepileptic drug prescriptions over a decade in childbearing women in Lombardy region, Italy

To describe the antiepileptic drug (AED) prescription pattern in pregnant women and women of childbearing age in the 2010–2019 period in the Lombardy region, Italy.

[1]  B. Mostacci,et al.  Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE) , 2020, Seizure.

[2]  S. Hernández-Díaz,et al.  Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006-2016: A study in the five Nordic countries, United States, and Australia. , 2020, Pharmacoepidemiology and drug safety.

[3]  A. Biraben,et al.  Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience—a European perspective , 2020, Journal of Neurology.

[4]  C. Dyer.  Sodium valproate: Sanofi is indicted in France for failing to warn adequately about birth defects , 2020, BMJ.

[5]  M. Loane,et al.  Prescription of antiepileptic medicines including valproate in pregnant women: A study in three European countries , 2019, Pharmacoepidemiology and drug safety.

[6]  T. Tomson,et al.  Declining malformation rates with changed antiepileptic drug prescribing , 2019, Neurology.

[7]  M. Loane,et al.  Did advice on the prescription of sodium valproate reduce prescriptions to women? An observational study in three European countries between 2007 and 2016 , 2019, Pharmacoepidemiology and drug safety.

[8]  B. Mostacci,et al.  Valproate and female patients: Prescribing attitudes of Italian epileptologists , 2019, Epilepsy & Behavior.

[9]  N. Nakasato,et al.  Examination of the prescription of antiepileptic drugs to prenatal and postpartum women in Japan from a health administrative database , 2019, Pharmacoepidemiology and drug safety.

[10]  M. Bonati,et al.  Perinatal outcome and healthcare resource utilization in the first year of life after antiepileptic exposure during pregnancy , 2019, Epilepsy & Behavior.

[11]  P. Damkier,et al.  Patterns and predictors for prescription of psychotropics and mood‐stabilizing antiepileptics during pregnancy in Denmark 2000–2016 , 2018, British journal of clinical pharmacology.

[12]  S. Kochen,et al.  Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry , 2018, The Lancet Neurology.

[13]  T. Laursen,et al.  Association Between Prenatal Valproate Exposure and Performance on Standardized Language and Mathematics Tests in School-aged Children , 2018, JAMA neurology.

[14]  A. Marson,et al.  Maternal Use of Antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children , 2018 .

[15]  D. Reith,et al.  Antiepileptic drug exposure in pregnancy and pregnancy outcome from national drug usage data , 2017, BMC Pregnancy and Childbirth.

[16]  B. Casassus.  France bans sodium valproate use in case of pregnancy , 2017, The Lancet.

[17]  J. Clayton-Smith,et al.  Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. , 2016, The Cochrane database of systematic reviews.

[18]  A. Alibrandi,et al.  Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011. , 2015, British journal of clinical pharmacology.

[19]  J. Perrin,et al.  The rise in chronic conditions among infants, children, and youth can be met with continued health system innovations. , 2014, Health affairs.

[20]  G. Requena,et al.  Antiepileptic drug use in seven electronic health record databases in Europe: A methodologic comparison , 2014, Epilepsia.

[21]  V. Smith,et al.  Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism , 2014, Archives of Disease in Childhood: Education & Practice Edition.

[22]  Mogens Vestergaard,et al.  Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. , 2013, JAMA.

[23]  M. Bialer.  Why are antiepileptic drugs used for nonepileptic conditions? , 2012, Epilepsia.

[24]  J. Hallas,et al.  Trends in utilization of antiepileptic drugs in Denmark , 2006, Acta neurologica Scandinavica.

[25]  G. Perugi,et al.  Antiepileptic drugs: indications other than epilepsy. , 2004, Epileptic disorders : international epilepsy journal with videotape.